EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY-NC-ND 4.0

A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ) hypertension in pregnancy guideline

Renuka Shanmugalingam, Helen L Barrett, Amanda Beech, Lucy Bowyer, Tim Crozier, Amanda Davidson, Marloes Dekker Nitert, Kerrie Doyle, Luke Grzeskowiak, Nicole Hall, Hicham Ibrahim Cheikh Hassan iD, Annemarie Hennessy und 16 weitere

Medical Journal of Australia · 17.06.2024 · 220 (11) · 582-591

DOI: 10.5694/mja2.52312 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Medical Journal of Australia, online erschienen am 19.05.2024. Verfasst von Renuka Shanmugalingam und 27 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Hospital, Sydney, NSW. Hauptthemen laut MEDLINE: Hypertension, Pregnancy-Induced. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Society of Obstetric Medicine of Australia and New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction Hypertensive disorders of pregnancy (HDP) affect up to 10% of all pregnancies annually and are associated with an increased risk of maternal and fetal morbidity and mortality. This guideline represents an update of the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) guidelines for the management of hypertensive disorders of pregnancy 2014 and has been approved by the National Health and Medical Research Council (NHMRC) under section 14A of the National Health and Medical Research Council Act 1992 . In approving the guideline recommendations, NHMRC considers that the guideline meets NHMRC's standard for clinical practice guidelines. Main recommendations A total of 39 recommendations on screening, preventing, diagnosing and managing HDP, especially preeclampsia, are presented in this guideline. Recommendations are presented as either evidence‐based recommendations or practice points. Evidence‐based recommendations are presented with the strength of recommendation and quality of evidence. Practice points were generated where there was inadequate evidence to develop specific recommendations and are based on the expertise of the working group. Changes in management resulting from the guideline This version of the SOMANZ guideline was developed in an academically robust and rigorous manner and includes recommendations on the use of combined first trimester screening to identify women at risk of developing preeclampsia, 14 pharmacological and two non‐pharmacological preventive interventions, clinical use of angiogenic biomarkers and the long term care of women who experience HDP. The guideline also includes six multilingual patient infographics which can be accessed through the main website of the guideline. All measures were taken to ensure that this guideline is applicable and relevant to clinicians and multicultural women in regional and metropolitan settings in Australia and New Zealand.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, Pregnancy-InducedHumansPregnancyFemaleAustraliaNew ZealandPre-EclampsiaSocieties, MedicalObstetricsAntihypertensive Agents

Stichwörter der Autor:innen

Guidelines as topicHypertensionPregnancy, high‐riskPre‐eclampsia

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Liverpool Hospital, Sydney, NSW.
  • Western Sydney University, Sydney, NSW.
  • Royal Hospital for Women, Sydney, NSW.
  • University of New South Wales, Sydney, NSW.
  • Monash Medical Centre, Melbourne, VIC.
  • Monash University, Melbourne, VIC.

ORCID-Profile: Hicham Ibrahim Cheikh Hassan, Katy Jl Bell, Deonna Ackermann

Förderung

  • Society of Obstetric Medicine of Australia and New Zealand

Zitieren

APA

Shanmugalingam, R., Barrett, H. L., Beech, A., Bowyer, L., Crozier, T., Davidson, A., Dekker Nitert, M., Doyle, K., Grzeskowiak, L., Hall, N., Cheikh Hassan, H. I., Hennessy, A., Henry, A., Langsford, D., Lee, V. W., Munn, Z., Peek, M. J., Said, J. M., Tanner, H., …, & Makris, A. (2024). A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ) hypertension in pregnancy guideline. Medical Journal of Australia, 220(11), 582-591. https://doi.org/10.5694/mja2.52312

Vancouver

Shanmugalingam R, Barrett HL, Beech A, Bowyer L, Crozier T, Davidson A, et al. A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ) hypertension in pregnancy guideline. Medical Journal of Australia. 2024;220(11):582-591. doi:10.5694/mja2.52312

BibTeX
@article{Shanmugalingam2024,
  author = {Shanmugalingam, Renuka and Barrett, Helen L and Beech, Amanda and Bowyer, Lucy and Crozier, Tim and Davidson, Amanda and Dekker Nitert, Marloes and Doyle, Kerrie and Grzeskowiak, Luke and Hall, Nicole and Cheikh Hassan, Hicham Ibrahim and Hennessy, Annemarie and Henry, Amanda and Langsford, David and Lee, Vincent Ws and Munn, Zachary and Peek, Michael J and Said, Joanne M and Tanner, Helen and Taylor, Rachel and Ward, Meredith and Waugh, Jason and Yen, Linda Ly and Medcalf, Ellie and Bell, Katy Jl and Ackermann, Deonna and Turner, Robin and Makris, Angela},
  title = {A summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand ( SOMANZ ) hypertension in pregnancy guideline},
  journal = {Medical Journal of Australia},
  year = {2024},
  volume = {220},
  number = {11},
  pages = {582--591},
  doi = {10.5694/mja2.52312}
}
Kostenlos starten →